Reply to: No Evidence that Glucosylsphingosine Is a Biomarker for Parkinson Disease.
Mov Disord
; 37(3): 654, 2022 03.
Article
in En
| MEDLINE
| ID: mdl-35092096
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Parkinson Disease
Type of study:
Diagnostic_studies
Limits:
Humans
Language:
En
Journal:
Mov Disord
Journal subject:
NEUROLOGIA
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: